Loading...
XSHE
300314
Market cap392mUSD
Jul 10, Last price  
9.43CNY
1D
2.06%
1Q
-26.67%
Jan 2017
-55.64%
IPO
18.92%
Name

Ningbo David Medical Device Co Ltd

Chart & Performance

D1W1MN
XSHE:300314 chart
P/E
31.20
P/S
4.68
EPS
0.30
Div Yield, %
0.94%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
4.13%
Revenues
581m
+10.15%
140,407,074149,790,265177,690,663206,741,295255,790,389217,245,092227,181,354219,427,411264,948,776303,905,401300,298,174356,352,075459,530,602474,132,641474,132,641506,036,692506,036,691618,298,237527,026,027580,516,564
Net income
87m
+52.02%
24,807,17228,956,96138,591,78453,968,74473,866,83964,071,73253,606,57744,934,20562,165,93047,033,17628,812,64162,056,597136,190,37980,206,69180,206,69397,358,60097,358,601147,610,91357,263,31787,053,319
CFO
104m
+11.23%
12,100,40041,220,88556,775,33167,018,85994,528,29756,490,57767,787,05648,409,95476,951,21954,740,45369,954,90088,569,835137,730,04751,480,031111,569,973135,198,38393,866,811104,405,411
Dividend
Jun 30, 20250.087 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ningbo David Medical Device Co., Ltd. is a global enterprise dedicated to the innovation, production, and worldwide distribution of medical equipment. The company's primary focus lies in providing essential neonatal care devices, such as infant incubators, transport incubators, infant radiant warmers, and phototherapy units for neonatal bilirubin. They also supply infant resuscitators. Beyond these core offerings, Ningbo David Medical Device Co., Ltd. manufactures a diverse range of other medical apparatus. These include infusion pumps, transcutaneous jaundice detectors, infant T-piece resuscitators, air/oxygen blenders, low-pressure aspirators, infant oxygen hoods, far infrared heaters, and infant head-fixing units. All products are marketed under the "David" brand. Established in 1992, the company maintains its headquarters in Ningbo, China.
IPO date
May 08, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT